Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Inhibrx Biosciences (INBX) EPS (Basic): 2023-2024

Historic EPS (Basic) for Inhibrx Biosciences (INBX) over the last 2 years, with Dec 2024 value amounting to $114.01.

  • Inhibrx Biosciences' EPS (Basic) rose 19.72% to -$2.28 in Q3 2025 from the same period last year, while for Sep 2025 it was -$11.96, marking a year-over-year decrease of 110.76%. This contributed to the annual value of $114.01 for FY2024, which is 656.69% up from last year.
  • Inhibrx Biosciences' EPS (Basic) amounted to $114.01 in FY2024, which was up 656.69% from -$20.48 recorded in FY2023.
  • Inhibrx Biosciences' 5-year EPS (Basic) high stood at $114.01 for FY2024, and its period low was -$20.48 during FY2023.
  • In the last 2 years, Inhibrx Biosciences' EPS (Basic) had a median value of $46.77 in 2023 and averaged $46.77.
  • Data for Inhibrx Biosciences' EPS (Basic) shows a peak YoY spiked of 656.69% (in 2024) over the last 5 years.
  • Yearly analysis of 2 years shows Inhibrx Biosciences' EPS (Basic) stood at -$20.48 in 2023, then skyrocketed by 656.69% to $114.01 in 2024.